公司董事及高級職員挪用資金的責任認定？申索得直

### 案件基本資料 - 案件名稱：CHINA MEDICAL TECHNOLOGIES, INC. (IN LIQUIDATION) 及其他人 訴 WU XIAODONG 及其他人 - 法院：高等法院原訟法庭 (Court of First Instance, CFI) - 法官：Hon Eugene Fung J - 判決日期：2026年1月16日 ### 案情摘要 第一原告CMED是一家於2004年在開曼群島註冊的上市公司，是CMED集團的最終控股公司，透過其全資子公司第二原告CMED Tech間接持有。CMED集團主要業務是在中國大陸開發、製造和銷售先進的醫療設備。CMED於2005年在納斯達克上市，並透過股權和債務發行籌集了約6.31億美元。2011年，CMED未能支付債券利息，導致其股票於2012年從納斯達克退市，並於同年被開曼群島法院清盤。本案涉及CMED及其子公司向其前董事、高級職員及其他第三方支付巨額款項，原告指控被告違反信託義務、非法手段串謀、欺詐性交易、不誠實協助、知情收受及不當得利。在23名被告中，只有3名被告出庭應訊。 ### 核心法律爭議 本案主要爭議點包括：吳曉東、曾德勇、陳忠和朱峰對CMED及CMED Tech負有何種義務？他們是否違反了這些義務？吳曉東、曾德勇、陳忠、朱峰和莊榮協之間是否存在串謀？吳曉東、曾德勇、陳忠、朱峰和Supreme Well是否明知而參與了以欺詐目的經營CMED業務？第5至23被告是否不誠實地協助了吳曉東、曾德勇、陳忠和/或朱峰違反信託義務？各被告是否須對知情收受負責？各被告是否須對不當得利負責？原告對曾德勇、陳忠、莊榮協、郝曉青和畢曉瓊的申索是否因時效而受阻？原告有權獲得何種補救措施？ ### 判決理由 法官裁定，吳曉東和曾德勇作為主要策劃者和執行者，透過欺詐性虛假陳述、不披露和故意隱瞞，導致CMED及CMED Tech以嚴重高估的價格進行FISH和SPR技術交易，從而挪用資金。朱峰亦參與了此欺詐行為。莊榮協透過偽造文件和參與串謀，協助挪用資金。郝曉青和畢曉瓊被認定不誠實地協助了吳曉東違反信託義務，因他們對資金來源和合法性存疑，卻故意不作查詢。法院認為，陳忠並未違反任何信託義務，且沒有證據表明他明知或參與了欺詐。對於時效抗辯，法院根據《時效條例》第26(1)(a)條和第26(1)(b)條，裁定原告對串謀、不誠實協助和知情收受的申索未過時效，因欺詐和故意隱瞞在2013年12月23日之前無法合理地被發現。然而，對不當得利的申索則受時效限制，除非能證明故意隱瞞。 ### 引用案例與條文 本案引用了多個案例來確立董事義務、不誠實協助、知情收受和時效的法律原則。其中包括： - Re Smith and Fawcett Ltd [1942] Ch 304：確立董事須真誠地為公司最佳利益行事。 - Hopcraft v Close Brothers Limited [2025] 3 WLR 423：確認董事與公司之間的信託關係。 - Sinclair Investments (UK) Ltd v Versailles Trade Finance Ltd [2012] Ch 453：將董事視為公司資產的受託人。 - Royal Brunei Airlines v Tan [1995] 2 AC 378 及 Ivey v Genting Casinos (UK) Ltd [2018] AC 391：確立不誠實協助的客觀不誠實標準及兩階段測試。 - BTI 2014 LLC v Sequana SA [2024] AC 211：討論董事考慮債權人利益的義務。 - Peconic Industrial Development Ltd v Lau Kwok Fai (2009) 12 HKCFAR 139：關於《時效條例》第20條的適用。 - Potter v Canada Square Operations Ltd [2024] AC 679：闡釋「故意隱瞞」的定義。 ### 裁決與命令 法院裁定原告勝訴，判令吳曉東、曾德勇和朱峰須就違反信託義務支付5.218億美元。吳曉東、曾德勇、朱峰和莊榮協須就非法手段串謀支付5.218億美元。吳曉東、曾德勇、朱峰和Supreme Well須就欺詐性交易支付5.218億美元。莊榮協、郝曉青、畢曉瓊及多個公司被告須就不誠實協助和知情收受支付不同金額。陳忠、莊榮協、郝曉青、畢曉瓊及多個公司被告須就不當得利支付不同金額。法院駁回原告對吳曉東、曾德勇、陳忠和朱峰追討薪金和報酬的申索，以及對陳忠的違反義務、非法手段串謀、欺詐性交易和知情收受的申索。法院亦駁回對郝曉青的不當得利申索，對Dynamic Sense和畢俊雲的不誠實協助和知情收受申索，以及對Max Proper的所有申索。 ### 判決啟示 本案強調了公司董事和高級職員在處理公司資產時的嚴格信託義務，以及在涉及欺詐行為時，法院如何運用推定和推論來認定責任。判決重申了不誠實協助和知情收受的客觀不誠實標準，並詳細闡述了《時效條例》第26條在欺詐和故意隱瞞情況下延長時效期的適用。此外，本案也澄清了在何種情況下，公司員工（非董事）會被視為負有信託義務，以及在不當得利申索中，被告的惡意行為對時效抗辯的影響。 --- ### 免責聲明 本摘要由人工智能自動生成，內容可能存在錯誤或遺漏，僅供參考，不構成法律意見。如需法律建議，請諮詢合資格律師。### Case Details - Case Name: CHINA MEDICAL TECHNOLOGIES, INC. (IN LIQUIDATION) & OTHERS v WU XIAODONG & OTHERS - Court: Court of First Instance (CFI) - Judge: Hon Eugene Fung J - Date of Judgment: 16 January 2026 ### Factual Background The 1st Plaintiff, CMED, a public company incorporated in the Cayman Islands in 2004, was the ultimate holding company of the CMED Group, held indirectly through its wholly-owned subsidiary, the 2nd Plaintiff, CMED Tech. The CMED Group's principal business was developing, manufacturing, and marketing advanced medical equipment in Mainland China. CMED was listed on NASDAQ in 2005 and raised approximately US$631 million through equity and debt offerings. In 2011, CMED failed to make bond coupon payments, leading to its delisting from NASDAQ in 2012 and subsequent winding-up by the Cayman Islands Court. This case involves substantial sums paid by CMED and CMED Tech to former directors, officers, and other third parties. The plaintiffs allege breaches of fiduciary duties, unlawful means conspiracy, fraudulent trading, dishonest assistance, knowing receipt, and unjust enrichment. Out of 23 defendants, only three appeared at trial. ### Key Legal Issues The core legal questions included: What duties did Wu Xiaodong, Samson Tsang, Chen Zhong, and Zhu Feng owe to CMED and CMED Tech? Did they breach these duties? Was there a conspiracy among Wu Xiaodong, Samson Tsang, Chen Zhong, Zhu Feng, and Chong Wing Hip? Were Wu Xiaodong, Samson Tsang, Chen Zhong, Zhu Feng, and Supreme Well knowingly parties to CMED's business being carried on for a fraudulent purpose? Did the 5th to 23rd Defendants dishonestly assist in breaches of fiduciary duties? Are the defendants liable for knowing receipt? Are they liable for unjust enrichment? Are the plaintiffs' claims against Samson Tsang, Chen Zhong, Chong Wing Hip, Hao Xiaoqing, and Bi Xiaoqiong time-barred? What remedies are the plaintiffs entitled to? ### Ratio Decidendi The judge found that Wu Xiaodong and Samson Tsang, as primary orchestrators, fraudulently caused CMED and CMED Tech to enter into FISH and SPR transactions at gross overvaluations through misrepresentations, non-disclosures, and deliberate concealments, enabling fund misappropriation. Zhu Feng was also implicated in this fraud. Chong Wing Hip assisted by procuring forged documents and participating in the conspiracy. Hao Xiaoqing and Bi Xiaoqiong were found to have dishonestly assisted Wu Xiaodong's breaches of fiduciary duties, having harboured suspicions about the funds' legitimacy but consciously refraining from inquiry. The court found Chen Zhong did not breach any fiduciary duties and lacked knowledge or involvement in the fraud. Regarding the limitation defence, the court applied sections 26(1)(a) and 26(1)(b) of the Limitation Ordinance, ruling that claims for conspiracy, dishonest assistance, and knowing receipt were not time-barred due to fraud and deliberate concealment not being discoverable with reasonable diligence before December 23, 2013. However, claims for unjust enrichment were time-barred unless deliberate concealment was proven. ### Key Precedents & Statutes This case cited several precedents establishing legal principles for directors' duties, dishonest assistance, knowing receipt, and limitation periods. These include: - Re Smith and Fawcett Ltd [1942] Ch 304: Established directors' duty to act bona fide in the company's best interests. - Hopcraft v Close Brothers Limited [2025] 3 WLR 423: Confirmed the fiduciary relationship between directors and the company. - Sinclair Investments (UK) Ltd v Versailles Trade Finance Ltd [2012] Ch 453: Treated directors as trustees of company assets. - Royal Brunei Airlines v Tan [1995] 2 AC 378 and Ivey v Genting Casinos (UK) Ltd [2018] AC 391: Established the objective standard of dishonesty and the two-stage test for dishonest assistance. - BTI 2014 LLC v Sequana SA [2024] AC 211: Discussed directors' duty to consider creditors' interests. - Peconic Industrial Development Ltd v Lau Kwok Fai (2009) 12 HKCFAR 139: Regarding the application of section 20 of the Limitation Ordinance. - Potter v Canada Square Operations Ltd [2024] AC 679: Clarified the definition of "deliberate concealment." ### Decision & Orders The court ruled in favour of the plaintiffs, ordering Wu Xiaodong, Samson Tsang, and Zhu Feng to pay US$521.8 million for breach of fiduciary duties. Wu Xiaodong, Samson Tsang, Zhu Feng, and Chong Wing Hip were ordered to pay US$521.8 million for unlawful means conspiracy. Wu Xiaodong, Samson Tsang, Zhu Feng, and Supreme Well were ordered to pay US$521.8 million for fraudulent trading. Chong Wing Hip, Hao Xiaoqing, Bi Xiaoqiong, and various corporate defendants were ordered to pay varying amounts for dishonest assistance and knowing receipt. Chen Zhong, Chong Wing Hip, Hao Xiaoqing, Bi Xiaoqiong, and various corporate defendants were ordered to pay varying amounts for unjust enrichment. The court dismissed plaintiffs' claims against Wu Xiaodong, Samson Tsang, Chen Zhong, and Zhu Feng for recovery of salaries and remuneration, and dismissed claims against Chen Zhong for breach of duty, unlawful means conspiracy, fraudulent trading, and knowing receipt. Unjust enrichment claims against Hao Xiaoqing, dishonest assistance and knowing receipt claims against Dynamic Sense and Ms JY Bi, and all claims against Max Prosper were also dismissed. ### Key Takeaways This judgment underscores the strict fiduciary duties of company directors and officers in handling company assets, and how courts use inferences to establish liability in fraud cases. It reaffirms the objective standard of dishonesty for dishonest assistance and knowing receipt, and elaborates on the application of Section 26 of the Limitation Ordinance for extending limitation periods in cases of fraud and deliberate concealment. The case also clarifies when employees (non-directors) may owe fiduciary duties and the impact of a defendant's bad faith on limitation defences in unjust enrichment claims. --- ### Disclaimer This summary is AI-generated and may contain errors or omissions. It is for reference only and does not constitute legal advice. Please consult a qualified lawyer for professional legal advice.